ConductScience.org, home

Paper23945239

Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy.

Johnson L and 27 others. J Clin Invest, 2013. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy. Papers, record 23945239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23945239

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy.
PubMed
Journal
J Clin Invest
PubMed
Year
2013
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
0.68
iCite
Revised in PubMed
2021-10-21
PubMed

Authors28

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Johnson LLeisa
2Huseni MMahrukh
3Smyczek TTanya
4Lima AAnthony
5Yeung SStacey
6Cheng JHJason H
7Molina RRafael
8Kan DDavid
9De Mazière AAnn
10Klumperman JJudith
11Kasman IIan
12Zhang YYin
13Dennis MSMark S
14Eastham-Anderson JJeffrey
15Jubb AMAdrian M
16Hwang OOlivia
17Desai RRupal
18Schmidt MMaike
19Nannini MAMichelle A
20Barck KHKai H

Source PubMed

See all 28 authorsDownload CSV of authors

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Angiogenesis InhibitorsMajor topic
AntibodiesMajor topic
ApoptosisMajor topic
Endothelial Growth FactorsMajor topic
Human Umbilical Vein Endothelial CellsMajor topic
Vascular Endothelial Growth Factor AMajor topic
Animals
Antibodies, Monoclonal, Humanized
Bevacizumab
Calcium-Binding Proteins
Carcinoma, Non-Small-Cell Lung
Clinical Trials, Phase I as Topic
EGF Family of Proteins
Humans
Insulinoma
Lung Neoplasms
Mice
Mice, Nude
Mice, Transgenic
Neoplastic Cells, Circulating
Neoplastic Stem Cells
Pancreatic Neoplasms
Tumor Burden
Tumor Cells, Cultured
Xenograft Model Antitumor Assays

Source PubMed

Download CSV of topics

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117626061EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution.Development2007https://conductscience.org/library/papers/17626061PubMed
215215160Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts.Am J Pathol2004https://conductscience.org/library/papers/15215160PubMed
322611036Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models.J Pathol2012https://conductscience.org/library/papers/22611036PubMed
419144677
The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of K-ras mutation status: analysis of a phase III study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancer.
Oncologist2009https://conductscience.org/library/papers/19144677PubMed
520947685Impaired angiogenesis and altered Notch signaling in mice overexpressing endothelial Egfl7.Blood2010https://conductscience.org/library/papers/20947685PubMed
615162510Egfl7, a novel epidermal growth factor-domain gene expressed in endothelial cells.Dev Dyn2004https://conductscience.org/library/papers/15162510PubMed
720213100Expression and clinical significance of EGFL7 in malignant glioma.J Cancer Res Clin Oncol2010https://conductscience.org/library/papers/20213100PubMed
89238051Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9238051PubMed
91570916250 years of preclinical anticancer drug screening: empirical to target-driven approaches.Clin Cancer Res2005https://conductscience.org/library/papers/15709162PubMed
1019861458Quantifying antivascular effects of monoclonal antibodies to vascular endothelial growth factor: insights from imaging.Clin Cancer Res2009https://conductscience.org/library/papers/19861458PubMed
1117934064Epidermal growth factor-like domain 7 protects endothelial cells from hyperoxia-induced cell death.Am J Physiol Lung Cell Mol Physiol2008https://conductscience.org/library/papers/17934064PubMed
1218854571Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE).J Clin Oncol2008https://conductscience.org/library/papers/18854571PubMed
1318268320Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18268320PubMed
1415085134The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation.Nature2004https://conductscience.org/library/papers/15085134PubMed
1522330688Antiangiogenic therapy--evolving view based on clinical trial results.Nat Rev Clin Oncol2012https://conductscience.org/library/papers/22330688PubMed
1616585151Contributions of human tumor xenografts to anticancer drug development.Cancer Res2006https://conductscience.org/library/papers/16585151PubMed
1722593194Genetically engineered mouse models: closing the gap between preclinical data and trial outcomes.Cancer Res2012https://conductscience.org/library/papers/22593194PubMed
1820495549Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models.Nat Biotechnol2010https://conductscience.org/library/papers/20495549PubMed
1910100573A phase I study of paclitaxel for mobilization of peripheral blood progenitor cells.Bone Marrow Transplant1999https://conductscience.org/library/papers/10100573PubMed
207168798Random-effects models for longitudinal data.Biometrics1982https://conductscience.org/library/papers/7168798PubMed

See all 31 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
37957249Low EGFL7 expression is associated with high lymph node spread and invasion of lymphatic vessels in colorectal cancer.Sci Rep2023https://conductscience.org/library/papers/37957249PubMed
35721105Recombinant EGFL7 Mitigated Pressure Overload-Induced Cardiac Remodeling by Blocking PI3K γ /AKT/ NFκB Signaling in Macrophages.Front Pharmacol2022https://conductscience.org/library/papers/35721105PubMed
33262827MicroRNA-126: A new and promising player in lung cancer.Oncol Lett2021https://conductscience.org/library/papers/33262827PubMed
32191808The EGFL7-ITGB3-KLF2 axis enhances survival of multiple myeloma in preclinical models.Blood Adv2020https://conductscience.org/library/papers/32191808PubMed
30065025EGFL7 enhances surface expression of integrin α5β1 to promote angiogenesis in malignant brain tumors.EMBO Mol Med2018https://conductscience.org/library/papers/30065025PubMed
29636300Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study.Clin Colorectal Cancer2018https://conductscience.org/library/papers/29636300PubMed
29483510EGFL7 reduces CNS inflammation in mouse.Nat Commun2018https://conductscience.org/library/papers/29483510PubMed
29438092Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First-Line Nonsquamous Non-Small Cell Lung Cancer.Oncologist2018https://conductscience.org/library/papers/29438092PubMed
28980146Egfl7 Represses the Vasculogenic Potential of Human Endothelial Progenitor Cells.Stem Cell Rev Rep2018https://conductscience.org/library/papers/28980146PubMed
28799610Viral nanoparticles decorated with novel EGFL7 ligands enable intravital imaging of tumor neovasculature.Nanoscale2017https://conductscience.org/library/papers/28799610PubMed
28539619Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab.Sci Rep2017https://conductscience.org/library/papers/28539619PubMed
28533390Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28533390PubMed
28275117Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer.Oncologist2017https://conductscience.org/library/papers/28275117PubMed
27535973Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection.Mol Cancer Ther2016https://conductscience.org/library/papers/27535973PubMed
27446447High expression levels of egfl7 correlate with low endothelial cell activation in peritumoral vessels of human breast cancer.Oncol Lett2016https://conductscience.org/library/papers/27446447PubMed
26775688Ten years of anti-vascular endothelial growth factor therapy.Nat Rev Drug Discov2016https://conductscience.org/library/papers/26775688PubMed
25705891A distinct mechanism of vascular lumen formation in Xenopus requires EGFL7.PLoS One2015https://conductscience.org/library/papers/25705891PubMed
25601901Notching on Cancer's Door: Notch Signaling in Brain Tumors.Front Oncol2014https://conductscience.org/library/papers/25601901PubMed
25142627High expression of epidermal growth factor-like domain 7 is correlated with poor differentiation and poor prognosis in patients with epithelial ovarian cancer.J Gynecol Oncol2014https://conductscience.org/library/papers/25142627PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
EGFL751162PubTator's text mininghttps://conductscience.org/library/genes/51162

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23945239

GET https://conductscience.org/api/papers/v1/23945239/authors?page=2